Close
Nordic 9Nordic 9

Bionova Capital (investor - Venture Capital)

Portugal bionovacapital.com
See something wrong or missing? Let us know
Offices:Lisbon

Bionova Capital (formerly Hovione Capital) is an independent, healthcare-focused venture capital firm, having been investing in early-stage life science companies since 2015.

Average round investment:12.07M USD
Average number per year:2.0
Distribution: 2021 (2)
Portfolio companies: United Kingdom SolasCureUnited Kingdom Adapttech
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bionova Capital

Name Criteria
United States Epidarex Capital
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
United Kingdom Future Planet Capital
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
South Korea Korea Investment Partners
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
United States Lionheart Ventures
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
Belgium Novalis Biotech
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
Italy Claris Ventures
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
United States Black Opal Ventures
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
Sweden Ash Pournouri
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
Sweden Niklas Zennström
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.1
United States Initialized Capital
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
Top